On opening day of SynBioBeta 2019 in San Francisco, CA, Kevin Ness, CEO of Inscripta, announced the company’s Onyx platform: the world’s first fully-automated digital genome engineering platform. Here’s how — and why — it works.5
Click here to join our weekly newsletter. We want to hear what you think about this article. Got a tip for our news team? Write to firstname.lastname@example.org.